University at Buffalo - The State University of New York

Join us for the February Life Sciences Commercialization Lecture Series. We will be featuring Jeff Harvey, CEO from Tonus Therapeutics, who will discuss his journey to find new ways of treating Duchenne muscular dystrophy. His collaboration with University at Buffalo researchers and personal investment in his work have lead his company down the path toward commercialization. In addition, we have Dr. Fred Sachs to speak on the science of Duchenne muscular dystrophy, including an overview of GsMTx4 and its application to the disease.